Zoetis Inc.
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- ZTS [1]
- Listing exchanges
- NYSE [1]
- SEC industry
- Pharmaceutical Preparations [1]
- Business sectors
- pharmaceutical industry [2]
- Company / filing name
- Zoetis Inc. [1]
- Headquarters location
- Florham Park [2]
- Business address
- 10 SYLVAN WAY, PARSIPPANY, NJ, 07054 [1]
- Founded
- 1952 [2]
- Legal form
- Delaware corporation [2]
- Official website
- www.zoetis.com ↗ [2]
- Annual revenue
- USD 8,080,000,000 · reported year 2022 [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US98978V1035 [2]
- CIK
- 0001555280 [1]
- SIC code
- 2834 [1]
- Country in background record
- United States [2]
Company positioning and business
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries. [3]
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. [3]
The firm is named Zoetis in allusion to the Greek-derived zoological term zoetic, meaning "pertaining to life". The company was owned by Pfizer until 2013. [3]
Background text: Wikipedia contributors, Zoetis. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Understanding company scale
Annual revenue: USD 8,080,000,000 · reported year 2022. [2]
Financial year, securities and disclosures
The SEC submissions record gives Zoetis Inc. a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: ZTS (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was Zoetis Inc. founded?
Founded: 1952. The linked source provides the background record. [2]
Where is the headquarters of Zoetis Inc.?
Headquarters location: Florham Park. The linked source provides the background record. [2]
Which business sectors are recorded for Zoetis Inc.?
Business sectors: pharmaceutical industry. The linked source provides the background record. [2]
Zoetis Inc. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — Zoetis Inc. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Zoetis (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.